Remove Confidentiality Remove Invention Remove Licensing Remove Settlement
article thumbnail

Methods of Commercializing Intellectual Property – Part I

Intepat

Things to Keep in Mind Maintaining Secrecy – Only inventions and designs which are not previously disclosed can be registered for patents and industrial designs. Therefore, it is important to make sure such confidential information is not publicised unauthorisedly. The ownership is not transferred.

article thumbnail

SpicyIP Weekly Review (March 4-March 10)

SpicyIP

The decision highlighted the Controller’s duty to consider existing knowledge and the inventive step properly. ” The Deputy Controller of Patents cited lack of novelty and inventive step (Section 2(1)(ja)) and non-compliance with Section 59(1).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

What is Blockchain Technology and has it been Patented?

Biswajit Sarkar Copyright Blog

Just like other patents, the patent protection on Blockchain also achieves exclusive rights to its inventor or assignee in exchange of details about the blockchain invented to be released in the public domain. An opt-in scheme could address the confidentiality concerns of IP owners.

article thumbnail

What is Blockchain Technology and has it been Patented?

Biswajit Sarkar Copyright Blog

Just like other patents, the patent protection on Blockchain also achieves exclusive rights to its inventor or assignee in exchange of details about the blockchain invented to be released in the public domain. An opt-in scheme could address the confidentiality concerns of IP owners.

article thumbnail

What is Blockchain Technology and has it been Patented?

Biswajit Sarkar Copyright Blog

Just like other patents, the patent protection on Blockchain also achieves exclusive rights to its inventor or assignee in exchange of details about the blockchain invented to be released in the public domain. An opt-in scheme could address the confidentiality concerns of IP owners.

article thumbnail

Biosimilars 2020 Year in Review

Fish & Richardson Trademark & Copyright Thoughts

For the first time since FDA licensed the first biosimilar, Sandoz’s Zarxio ® (filgrastim-sndz), in 2015, the United States saw a decrease in annual biosimilar approvals in 2020. No earlier than July 31, 2023 per settlement. No earlier than November 20, 2023 per settlement. . No earlier than June 30, 2023 per settlement.

article thumbnail

India’s High Court of Delhi issues guidance on SEP licensing that seeks to harmonize decisions in other countries (Intex v. Ericsson)

LexBlog IP

This is an important decision to review in understanding licensing and litigation of international SEP portfolios. This decision indicates that a FRAND commitment is not a one-way street, but imposes obligations on both the SEP owner and someone seeking to license the SEP. those who stall licensing negotiations).